Metabolon’s Untargeted Metabolomics Services Used for Breakthrough Study Revealing Powerful Link Between Gut Microbiome, the Metabolome, and Type 2 Diabetes (T2D)
Combining metabolomics, gut microbiome, and clinical data may help prevent and personalize the treatment of type 2 diabetes MORRISVILLE, N.C., July 1, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision...
IMG Launches First ‘Student Journey Scholarship’ for International Students in the U.S.
INDIANAPOLIS, July 1, 2025 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is excited to launch its inaugural Student Journey Scholarship, a new program designed to help international students fund their studies at a U.S. college or university. IMG will be awarding funds to...
Anta Group’s HEMIN Foundation Releases First Report Focusing on Medical Donations Over Three Years: Cumulative Donations Exceed RMB 650 Million
JINJIANG, China, July 1, 2025 /PRNewswire/ -- On July 1, Anta Group's HEMIN Foundation released its first report covering the years 2021–2024. The Foundation was established in December 2021 with an announcement of RMB 10 billion donation from Anta Group's founding family. Upholding the charitable philosophy of the Founder of Anta Group and Honorary Chairman of the Foundation, Mr. Ding...
WuXi XDC Announces the Mechanical Completion of its Singapore Site, Accelerating the Global Expansion of Bioconjugates Manufacturing
SHANGHAI and SINGAPORE, July 1, 2025 /PRNewswire/ -- On June 30, WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the mechanical completion of its manufacturing site at Tuas Biomedical Park in Singapore has been successfully achieved. This milestone signifies that this manufacturing...
Pioneering Global Presence, Empowering the World – Zuowei Technology Shining at WHX Miami Medical Expo
SHENZHEN, China, July 1, 2025 /PRNewswire/ -- From June 11 to 13, the 2025 WHX Miami Medical Expo (formerly known as FIME), the annual grand event of the medical industry in the Americas, was held at the Miami Beach Convention Center. As one of the largest and most influential professional exhibitions for medical devices and equipment in the Americas, WHX Miami...
HanchorBio and Henlius Sign Major Licensing Deal for HCB101 to Expand Global Immuno-Oncology Reach
TAIPEI and SHANGHAI and SAN FRANCISCO, July 1, 2025 /PRNewswire/ -- HanchorBio Inc. (7827.TWO), a global clinical-stage biotechnology company developing innovative immunotherapies for oncology and autoimmune diseases, today announces the signing of a major out-licensing agreement with Shanghai Henlius Biotech, Inc. (hereafter "Henlius"). The deal grants Henlius exclusive development and commercialization rights to HCB101 across Greater China (including...
CentraLlVF Launches New Guaranteed Egg Donation Programs Through CEB and AWEB
Expanded blastocyst-guarantee programs now available through two CentraLlVF brands, supporting a wider range of Australian recipients LONDON, July 1, 2025 /PRNewswire/ -- CentraLlVF, a leading Australian provider of donor egg solutions, is proud to announce important program updates across both of its egg donation brands: Central Egg Bank (CEB) and Australia-Wide Egg Bank (AWEB). Designed specifically...
Australian digital health leaders come together to enable solutions for overlooked health challenges: Winners announced
Apps tackling nutritional literacy in migrant communities and child sleep issues to be developed, co-designed, tested and delivered to target populations as part of the Priority Digital Health Challenge 2025. SYDNEY, July 1, 2025 /PRNewswire/ -- Australia's digital health leaders have crowned two experts from Griffith University and University of Melbourne as winners of the...
Wingderm USA Takes the Lead at TAS 2025, Cementing Its Local Presence in the U.S.
BEIJING, July 1, 2025 /PRNewswire/ -- Wingderm®, a leading innovator in energy-base medical aesthetic technologies, officially made its debut at The Aesthetic Show (TAS) 2025, held from June 27 to 29 in Las Vegas. This marks a key step as the brand grows in the U.S. medical aesthetic market. At TAS,...
AvenCell Awarded Up to $40 Million AMED Grant to Advance Allogeneic CAR-T Program
TOKYO, June 30, 2025 /PRNewswire/ -- AvenCell Japan, a wholly owned subsidiary of AvenCell Therapeutics, a private, clinical-stage biotechnology company developing best-in-class CAR-T therapies for hematologic cancers and autoimmune diseases, today announced it has been awarded a grant of up to $40 million from the Japan Agency for Medical Research...
